Raidium
AI NativeThe AGI radiology company Between Paris & Palo Alto [StartX F2025]
Est 2022|Valuation $55.6M|Raised $18.2M
The AGI radiology company Between Paris & Palo Alto [StartX F2025]
Published Jul 14, 2026
Public signals show the vendor participates in major radiology venues (e.g., RSNA exhibitor listings) and has press mentions. These signals indicate vendor market activity but not established adoption at scale.
Sources: Official exhibitor listings from major industry conferences and general press mentions
| Starting Price | Not publicly listed | Public-sector listing exists; pricing varies by procurement context | Public pricing page with tiering / per-study options |
| Suitable For | Organizations evaluating an integrated viewer with an embedded foundation model for imaging workflows | Hospitals seeking an AI deployment and monitoring platform to integrate multiple third-party radiology AIs | Imaging organizations seeking a cloud PACS + viewer with clearer entry pricing |
| Key Strength | Vendor-stated integrated viewer with an embedded foundation model; research-oriented outputs | Focus on AI deployment, monitoring, and integration into existing workflows (orchestration) | Cloud-native PACS positioning; more transparent entry-level pricing information |
| Key Weakness | Limited publicly available third-party validation and customer reviews; pricing and enterprise security details are not transparent | May depend on the underlying PACS/viewer environment; value depends on supported algorithms and integrations | Suitability for complex, large-scale enterprise deployments depends on architecture and data residency needs |
—
Market commentary indicates vendor participation in industry events and press coverage, which is consistent with active marketing and outreach but does not constitute evidence of broad clinical adoption.
Sources (incumbent pricing sentiment / market commentary): Industry Reddit and community threads